Effects of Repetitive Transcranial Magnetic Stimulation (rEMT) in Obesity
Not Applicable
Recruiting
- Conditions
- ObesityC18.654.726.750
- Registration Number
- RBR-9x9kctn
- Lead Sponsor
- Instituto de Neuromodulação e Reabilitação Avançada (INERVA)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Adult volunteers; 18 to 59 years of age; of both sexes; diagnosed with obesity to any degree for body mass index (BMI)
Exclusion Criteria
Eutrophic, overweight and malnourished volunteers for BMI; who have contraindications to rEMT or have received rEMT in the last 12 months; who present any head injury, previously documented epilepsy, presence of psychiatric disorder (schizophrenia and bipolar disorder); who have metal implants in their heads; who use or have used anti-obesity drugs (sibutramine, topiramate, orlistat and liraglutide) in the last 3 months; who are addicted to illicit drugs in the last 5 years; who have Cushing's Syndrome; who are pregnant or breastfeeding
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected to find a reduction in subjective levels of hunger and increased satiety in obese patients, verified by the Visual Analogue Scale (VAS), from a reduction in measurements of 60% comparing sham group and treatment
- Secondary Outcome Measures
Name Time Method A reduction of 5% in anthropometric measurements is expected, as verified by physical evaluation, comparing sham group and treatment;A reduction in the level of binge eating is expected to be 5%, verified by the Binge Eating Scale, comparing the sham group and treatment;Modifications in laboratory tests of 5% are expected, verified by biochemical tests, comparing sham group and treatment